Pasteur Mérieux Sérums et Vaccins S.A.
36Patents
0Active
36Granted
35Portfolio score
Filing activity: Feb 3, 1988 → May 7, 2004
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5436135A | New preparation of placenta collagen, their extraction method and their applications | Human Necessities | 93 | Expired |
| US5498427A | Solutions for the perfusion, preservation and reperfusion of organs | Human Necessities | 74 | Expired |
| US5846946A | Compositions and methods for administering Borrelia DNA | Emerging Cross-Sectional Technologies | 47 | Expired |
| US6126938A | Methods for inducing a mucosal immune response | Emerging Cross-Sectional Technologies | 33 | Expired |
| US6045805A | Oligosaccharide derived from an antigenic polysaccharide obtained from a pathogenic agent | Emerging Cross-Sectional Technologies | 31 | Expired |
| US6008036A | Method for purifying viruses by chromatography | Emerging Cross-Sectional Technologies | 29 | Expired |
| US6174708A | Preparation of a multicombinatorial library of antibody gene expression vectors | Chemistry; Metallurgy | 27 | Expired |
| US5654135A | Biomaterial based on collagen and its application | Chemistry; Metallurgy | 25 | Expired |
| US6231860A | Stabilizers for live vaccines | Chemistry; Metallurgy | 25 | Expired |
| US6124270A | Use of a cationic amphipathic compound as a transfection agent, vaccine additive or drug | Emerging Cross-Sectional Technologies | 22 | Expired |
| US5079337A | Macromolecular conjugates of hemoglobin, a procedure for their preparation and their uses | Human Necessities | 19 | Expired |
| US6028049A | Compositions comprising the Tbp2 subunit of the transferrin receptor of Neisseria meningitidis | Chemistry; Metallurgy | 19 | Expired |
| US5184450A | Method of packaging freeze dried vaccines in syringes and plug for implementing the method | Human Necessities | 18 | Expired |
| US6007818A | Oligosaccharide derived from an antigenic polysaccharide obtained from a pathogenic agent | Emerging Cross-Sectional Technologies | 18 | Expired |
| US5756101A | Malaria recombinant poxvirus | Emerging Cross-Sectional Technologies | 16 | Expired |
| US6214353A | Malaria recombinant poxvirus vaccine | Emerging Cross-Sectional Technologies | 15 | Expired |
| US6048537A | Method for preparing an influenza virus, antigens obtained and applications thereof | Chemistry; Metallurgy | 15 | Expired |
| US6451769B1 | Compositions and methods for administering Borrelia DNA | Emerging Cross-Sectional Technologies | 14 | Expired |
| US6420160B1 | Virus-like particles useful as a vector for delivering nucleic acid | Chemistry; Metallurgy | 14 | Expired |
| US6284249A | Fusion polypeptide having the C protein and E1 protein of hepatitis C virus | Emerging Cross-Sectional Technologies | 13 | Expired |
| US6599697B1 | Process for preparing a multicombinatorial library of vectors for expressing antibody genes | Chemistry; Metallurgy | 11 | Expired |
| US5346992A | Process for isolating human albumin from supernatant IV, in particular IV-4, or from COHN's fraction V or from an analogous supernatant or fraction | Chemistry; Metallurgy | 11 | Expired |
| US6149917A | Industrial production process for a vaccine against Japanese encephalitis virus and vaccine produced | Emerging Cross-Sectional Technologies | 9 | Expired |
| US5618541A | Vaccine against Neisseria meningitidis infections | Emerging Cross-Sectional Technologies | 9 | Expired |
| US6333036A | Vaccine composition containing polyribosylribitol phosphate and method for making same | Emerging Cross-Sectional Technologies | 8 | Expired |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.